Thinking of joining a study?

Register your interest

NCT01608152 | RECRUITING | Leukemia


Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
Sponsor:

M.D. Anderson Cancer Center

Brief Summary:

This trial collects feedback from patients to develop a video game in improving the outcomes in stem cell transplant survivors. A video game may help to improve health behaviors for leukemia or lymphoma patients after stem cell transplant.

Condition or disease

Leukemia

Lymphoma

Intervention/treatment

Focus Group

Internet-Based Intervention

Interview

Detailed Description:

PRIMARY OBJECTIVES: I. Develop a prototype intervention electronic game that implements a baseline testable feature set, including features for social networking within a virtual game space, managing an intermittent mediated reward cycle, goal setting and tracking, and collaborative problem solving. II. Evaluate the technical merit, feasibility, user perception and acceptance of the prototype system with adolescents and young adults (AYAs) allogeneic hematopoietic stem cell transplantation (HSCTs) patients in recovery. III. Based on the results of the prototype evaluation, enhance and complete development of the Stempowerment on-line intervention. IV. This is a single arm study with no comparison group; therefore, the purpose is to evaluate the impact of the Stempowerment intervention on OUTLINE: Patients are assigned to 1 of 2 groups. GROUP I: Patients attend a focus group for up to 1.5 hours and provide feedback on design elements, specific desirable features, and preferences for the initial prototype. GROUP II: Patients have access to the game for 3 weeks and then provide feedback on problems or questions regarding the use of the prototype.

Study Type : OBSERVATIONAL
Estimated Enrollment : 40 participants
Official Title : Using Game Mechanics to Improve Outcomes Among Stem Cell Transplant Survivors
Actual Study Start Date : 2013-02-20
Estimated Primary Completion Date : 2026-12-31
Estimated Study Completion Date : 2026-12-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 15 Years to 39 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • Phase I
  • The target population for this study will consist of
    • 1. Individuals ages 15-29
    • 2. Able to read and speak English
    • 3. Diagnosis of leukemia or lymphoma
    • 4. First time allogeneic SCT recipient
    • Phase II
    • The target population for this study will consist of
      • 1. Individuals ages 18-39 (in phase I, we recruited only individuals age 15-29. For phase II, we will recruit young adults, and will expand the eligible age range up to 39 years. This expansion in age eligibility to 39 years is consistent with the National Cancer Institute definition of adolescents and young adults with cancer, and is consistent with the age range of patients seen at MD Anderson in the Adolescent and Young Adult Center.
      • 2. Able to read and speak English
      • 3. Diagnosis of leukemia or lymphoma (including Myelodysplastic Syndrome - MDS) or lymphoma
      • 4. HSCT recipient
      Exclusion Criteria
      • Phase I
      • The target population will be excluded if
        • 1. They do not speak English
        • 2. They have vision problems
        • 3. They have cognitive problems
        • 4. They have psychological difficulties
        • Phase II
        • The target population will be excluded if
          • 1. They do not speak English
          • 2. They have vision problems that would preclude them from viewing a computer screen.
          • 3. They have an intellectual deficiency that would prevent the potential participant from understanding information delivered on the computer platform or as defined by the DSM-V Diagnostic and Statistical Manual of Mental Disorders that would prevent them from understanding information delivered on the computer platform.

Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

Location Details

NCT01608152


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, Texas

M D Anderson Cancer Center

Houston, Texas, United States, 77030

Loading...